These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Jäkälä P; Sirviö J; Riekkinen P; Haapalanna A; Riekkinen P Pharmacol Biochem Behav; 1992 Aug; 42(4):903-7. PubMed ID: 1355298 [TBL] [Abstract][Full Text] [Related]
64. Osthole improves aspects of spatial performance in ovariectomized rats. Hsieh MT; Hsieh CL; Wang WH; Chen CS; Lin CJ; Wu CR Am J Chin Med; 2004; 32(1):11-20. PubMed ID: 15154281 [TBL] [Abstract][Full Text] [Related]
65. Beetroot supplemented diet exhibit anti-amnesic effect via modulation of cholinesterases, purinergic enzymes, monoamine oxidase and attenuation of redox imbalance in the brain of scopolamine treated male rats. Olasehinde TA; Oyeleye SI; Ibeji CU; Oboh G Nutr Neurosci; 2022 May; 25(5):1011-1025. PubMed ID: 33054666 [TBL] [Abstract][Full Text] [Related]
66. Effect of scopolamine on visual attention in rats. Jones DN; Higgins GA Psychopharmacology (Berl); 1995 Jul; 120(2):142-9. PubMed ID: 7480545 [TBL] [Abstract][Full Text] [Related]
67. The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task. Sirviö J; Lukkarinen K; Riekkinen P; Koivisto E; Virtanen R; Pennanen A; Valjakka A; Riekkinen PJ Pharmacol Biochem Behav; 1991 Aug; 39(4):1015-9. PubMed ID: 1684866 [TBL] [Abstract][Full Text] [Related]
68. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test. Smythe JW; Bhatnagar S; Murphy D; Timothy C; Costall B Brain Res Bull; 1998; 45(1):89-93. PubMed ID: 9434207 [TBL] [Abstract][Full Text] [Related]
69. Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice. Sansone M; D'Udine B; Renzi P; Vetulani J Psychopharmacology (Berl); 1987; 93(2):155-7. PubMed ID: 2892221 [TBL] [Abstract][Full Text] [Related]
73. Effect of prior experience of an environment on scopolamine-induced changes in activity. Stewart WJ Neurosci Lett; 1975 Sep; 1(3):173-7. PubMed ID: 19604782 [TBL] [Abstract][Full Text] [Related]
74. Environmental complexity does affect scopolamine induced changes in activity. Stewart WJ Neurosci Lett; 1975 Aug; 1(2):121-5. PubMed ID: 19604764 [TBL] [Abstract][Full Text] [Related]
75. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. Pertovaara A; Haapalinna A; Sirviö J; Virtanen R CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294 [TBL] [Abstract][Full Text] [Related]
76. Systemic administration of atipamezole, an alpha 2-antagonist, can reduce scopolamine-induced hyperactivity in rats. Niittykoski M; Hakkarainen V; Puumala T; Lappalainen R; Ruotsalainen S; Haapalinna A; Sirviö J Behav Pharmacol; 1997 Oct; 8(5):465-70. PubMed ID: 9832985 [TBL] [Abstract][Full Text] [Related]
77. The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats. Janas AM; Cunningham SC; Duffy KB; Devan BD; Greig NH; Holloway HW; Yu QS; Markowska AL; Ingram DK; Spangler EL Life Sci; 2005 Jan; 76(10):1073-81. PubMed ID: 15620572 [TBL] [Abstract][Full Text] [Related]
78. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks. Barbelivien A; Nyman L; Haapalinna A; Sirviö J Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370 [TBL] [Abstract][Full Text] [Related]
79. Does scopolamine block the development of ethanol-induced behavioral sensitization? Takahashi S; Fornari RV; Quadros IM; Oliveira MG; Souza-Formigoni ML Alcohol Clin Exp Res; 2007 Sep; 31(9):1482-9. PubMed ID: 17624998 [TBL] [Abstract][Full Text] [Related]
80. Spinal and pontine alpha2-adrenoceptors have opposite effects on pain-related behavior in the neuropathic rat. Wei H; Pertovaara A Eur J Pharmacol; 2006 Dec; 551(1-3):41-9. PubMed ID: 17027962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]